Skip to content
  • Monday, 12 October 2026
  • 7:14 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • FDA Public Hearing Examines the Future of Psychedelic Therapeutics and Balanced Regulatory Pathways
Pharmaceutical R&D

FDA Public Hearing Examines the Future of Psychedelic Therapeutics and Balanced Regulatory Pathways

Teuku Ryan Sep 20, 2026 0

On September 14, the United States Food and Drug Administration (FDA) convened a landmark public hearing to address the evolving…

Read More
Data Science & Bioinformatics

Auditing Model Bias with Balanced Datasets with Mimesis

Evan Lee Salim May 25, 2026 0

The increasing integration of machine learning solutions into critical societal functions, from financial services to healthcare and criminal justice, has…

Read More
CEPI Fast-Tracks Three Ebola Vaccine Candidates from IAVI, Moderna, and Oxford Amidst Bundibugyo Outbreak in DRC and UgandaPaternal Age and Genetic Risk: New Research Reveals How Natural Selection in Sperm Favors Disease-Causing MutationsBioengineered Bone Marrow-on-a-Chip Breakthrough Paves Way for Advanced Drug Screening and Space Medicine ResearchGut-Brain Signaling Pathways Reveal Distinct Neural Responses to Fructose and Glucose Intake
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions
2026 PharmSci 360 adds tracks on research credibility and post-animal drug developmentTeva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia CareTWiV 1288: Clinical update with Dr. Daniel Griffin | Microbe TVScientists discover a hidden factor that can make or break chemical reactions
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
Lana Keisha Oct 12, 2026
Pharmaceutical R&D
Teva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia Care
Teuku Ryan Oct 12, 2026
Microbiology & Immunology
TWiV 1288: Clinical update with Dr. Daniel Griffin | Microbe TV
Lina Irawan Oct 12, 2026
Advanced Materials Science
Scientists discover a hidden factor that can make or break chemical reactions
Nila Kartika Wati Oct 12, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ